Rapid and accurate determination of (CAG)n repeats in the androgen receptor gene using polymerase chain reaction and automated fragment analysis

被引:29
作者
Bharaj, BS
Vassilikos, EJK
Diamandis, EP
机构
[1] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
[2] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L5, Canada
关键词
gene polymorphisms; CAG repeats; androgen receptor; prostate cancer; fragment analysis;
D O I
10.1016/S0009-9120(99)00023-5
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: To develop and evaluate a new method for determination of the CAG repeat length in Exon 1 of the androgen receptor gene. Design and Methods: The method is based on PCR amplification of a DNA region encompassing the repeats and analysis of the length of the PCR product on a sequencing gel. One of the PCR primers was labeled with Cy5.5 fluorescent dye to facilitate detection after laser excitation. We used a fully automated system for electrophoretic separation of the PCR product and accurate sizing of the length of the PCR product using fragment analysis. Results: The major advantages of the new technique are its simplicity, speed, accuracy, and reproducibility. Analysis of the CAG repeats in genomic DNAs from 18 males indicated that they were all hemizygous with a mean CAG repeat number of 22 (range 20-30 repeats). Among 60 DNAs from females, 16 were homozygous and 44 were heterozygous. The repeat length ranged from 17-30 with a mean of 22. In both males and females, the distribution of CAG repeats was bimodal. Conclusion: We anticipate that this improved method for CAG repeat analysis will find applications in clinical studies involving prostate and breast cancer patients. Copyright (C) 1999 The Canadian Society of Clinical Chemists.
引用
收藏
页码:327 / 332
页数:6
相关论文
共 25 条
[11]  
Hakimi JM, 1997, CLIN CANCER RES, V3, P1599
[12]   Androgen receptor CAG repeat lengths in prostate cancer: Correlation with age of onset [J].
Hardy, DO ;
Scher, HI ;
Bogenreider, T ;
Sabbatini, P ;
Zhang, ZF ;
Nanus, DM ;
Catterall, JF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (12) :4400-4405
[13]  
IRVINE RA, 1995, CANCER RES, V55, P1937
[14]   The CAG/polyglutamine tract diseases: Gene products and molecular pathogenesis [J].
Koshy, BT ;
Zoghbi, HY .
BRAIN PATHOLOGY, 1997, 7 (03) :927-942
[15]   Breast and prostate cancer: An analysis of common epidemiological, genetic, and biochemical features [J].
López-Otín, C ;
Diamandis, EP .
ENDOCRINE REVIEWS, 1998, 19 (04) :365-396
[16]   DEFINITION OF THE HUMAN ANDROGEN RECEPTOR GENE STRUCTURE PERMITS THE IDENTIFICATION OF MUTATIONS THAT CAUSE ANDROGEN RESISTANCE - PREMATURE TERMINATION OF THE RECEPTOR PROTEIN AT AMINO-ACID RESIDUE 588 CAUSES COMPLETE ANDROGEN RESISTANCE [J].
MARCELLI, M ;
TILLEY, WD ;
WILSON, CM ;
GRIFFIN, JE ;
WILSON, JD ;
MCPHAUL, MJ .
MOLECULAR ENDOCRINOLOGY, 1990, 4 (08) :1105-1116
[17]  
Muglia M, 1996, CLIN CHEM, V42, P1601
[18]   Cancer statistics, 1996 [J].
Parker, SL ;
Tong, T ;
Bolden, S ;
Wingo, PA .
CA-A CANCER JOURNAL FOR CLINICIANS, 1996, 46 (01) :5-27
[19]  
Platz EA, 1998, CANCER EPIDEM BIOMAR, V7, P379
[20]  
Ross RK, 1998, CANCER RES, V58, P4497